Overview
Title
To provide funding for programs and activities under the SUPPORT for Patients and Communities Act.
ELI5 AI
The "Turn the Tide Act" is a plan that wants to spend lots of money to help people who have trouble with drugs. It will give money to places that help people get better and train more doctors, but it needs to make sure it's using the money wisely and fairly.
Summary AI
The bill, titled the "Turn the Tide Act," proposes allocating funds to enhance programs under the SUPPORT for Patients and Communities Act, aiming to combat substance use disorders. It authorizes and appropriates billions of dollars from 2024 to 2028 for various initiatives, including grants for substance use disorder treatment, public health enhancements, and support for affected communities. The bill also seeks to eliminate insurance barriers to medication-assisted treatment and reduce cost-sharing for opioid overdose reversal medications. Additionally, it aims to support healthcare workforce development, enhance Medicaid payments for mental and behavioral health services, and extend programs to support community recovery and law enforcement mental health initiatives.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
The Turn the Tide Act, or S. 3663, is a proposed bill intended to allocate funding for various programs under the SUPPORT for Patients and Communities Act. This legislation seeks to provide resources for a range of initiatives related to substance use disorder treatment, mental health education, opioid recovery, and law enforcement support.
General Summary
This bill is a comprehensive legislative proposal that involves substantial financial investment in combating substance use disorders and supporting related public health initiatives. By amending existing laws, it establishes appropriations across multiple sectors, including health care, housing, law enforcement, and community support. The funding spans a period from 2024 to 2027, with some initiatives extending even further. Key elements include increased funding for addiction treatment programs, opioid overdose prevention, and support for adverse childhood experiences. Additionally, the bill aims to eliminate insurance hurdles for medication-assisted treatments and proposes recovery housing for individuals with opioid use disorder under Medicaid.
Significant Issues
One of the major issues with the bill is the extensive appropriation of funds without detailed oversight mechanisms or accountability measures. Sections like SEC. 5 allocate $5.5 billion annually for state grants, raising concerns about potential wasteful spending without robust criteria or controls in place. In another example, SEC. 4 prioritizes states with high drug overdose rates for recovery housing funds but may overlook preventive strategies needed in states with emerging problems.
Furthermore, the usage of the phrase "out of any monies in the Treasury not otherwise appropriated" in several sections raises concerns about the prioritization of funds and financial oversight. This could suggest a lack of clear budgetary plans or constraints. There is also apprehension about the complexity of implementing several amendments across different acts, as seen in SEC. 7, which targets cost-sharing limitations for opioid overdose reversal medications.
Impact on the Public
Broadly, the bill aims to address the opioid crisis and substance use disorders, which remain critical public health challenges. By increasing funding and removing access barriers, it could facilitate better treatment options and support for individuals affected by these issues. For the general public, this could mean increased access to recovery services and health education, potentially leading to a reduction in substance use disorders and related societal impacts.
Impact on Specific Stakeholders
For patients with substance use disorders, the bill offers promise in terms of improved access to treatments and support services. Health care providers might see an expansion in funding opportunities and the ability to offer more comprehensive care. However, this could also lead to heightened administrative responsibilities due to increased federal oversight.
Insurance providers could face financial implications due to the cost-sharing limitations imposed by the bill, potentially affecting premium structures. Furthermore, state and local governments might benefit from increased funding but also face challenges in fulfilling the criteria for fund allocation and managing oversight requirements.
Law enforcement agencies could gain additional resources to support mental health and peer mentoring programs, yet they might struggle with the lack of specified success metrics, which could hinder program efficacy and accountability.
In summary, while the Turn the Tide Act presents an ambitious effort to tackle substance use disorders and related challenges, careful attention to oversight, clear allocation criteria, and manageable implementation strategies will be critical to its success and sustainability.
Financial Assessment
The "Turn the Tide Act" proposes significant financial allocations to enhance various programs aimed at combating substance use disorders. Here's a detailed overview of how the financial references interact with the issues identified in the bill.
Summary of Financial Allocations
The bill authorizes and appropriates funds from the U.S. Treasury for several key initiatives. Notably, it provides $5,500,000,000 annually from 2024 to 2028 for state grants for substance use disorder treatment under Section 5. This substantial allocation seeks to bolster efforts at the state level but may raise concerns about oversight and the potential for wasteful spending if not managed proficiently.
Further allocations include funding for specific public health programs, such as $75,000,000 annually directed towards mental and behavioral health education and training grants under Section 3. These funds aim to support comprehensive healthcare workforce development, ensuring an adequately trained workforce to address mental health needs.
In addition, Section 4 involves financial measures for housing and Department of Justice initiatives, including $60,000,000 annually for a recovery housing program, extended to 2029. The prioritization based on drug overdose death rates may skew fund distribution towards states with higher overdose rates, potentially neglecting preventive measures in other states.
Analysis of Financial References and Issues
Oversight and Accountability Concerns
The large-scale funding allocations, especially the $5,500,000,000 annually for state grants, spotlight issues regarding oversight mechanisms. Without stringent criteria or accountability measures, there's a risk that the funds might be distributed or utilized inefficiently. This may lead to concerns about potential wasteful spending, as emphasized in the identified issues, which highlights the need for robust management and oversight structures.
Prioritization and Distribution
The allocation of $60,000,000 annually for recovery housing and the associated weighting of 70% for drug overdose death rates raises concerns about equitable distribution. This could lead to an imbalance where states with higher overdose rates receive more resources, overshadowing states that might focus on preventive strategies. This approach might unintentionally sideline efforts in states with different priorities.
Budgetary Impact and Treasury Reserves
The repeated use of the phrase "out of any monies in the Treasury not otherwise appropriated" across multiple sections may raise issues concerning the prioritization of budget allocations. This language suggests that funds are being allocated from unspecified Treasury reserves, which could generate concerns about fiscal management, transparency, and overall budgetary impacts on other programs.
Program Effectiveness and Evaluation
Another concern is the financial management around initiatives like the law enforcement mental health programs, which receive $15,000,000 annually without specified success metrics. This could lead to challenges in assessing the effective use of funds and the ethical implications of such investments.
Furthermore, while the appropriations are substantial for training and education, such as the $75,000,000 annually for mental health training, the lack of oversight or specific monitoring mechanisms might result in inefficient fund usage, questioning the long-term impact and sustainability of such investments.
Conclusion
The "Turn the Tide Act" involves substantial financial commitments across various initiatives, each aiming to tackle the pervasive issue of substance use disorders. However, the bill's success will heavily depend on the implementation of rigorous oversight and transparent allocation practices to ensure that funds are used effectively and equitably across different states and programs. Addressing these financial management concerns is crucial in maximizing the bill's intended impact.
Issues
The allocation of $5,500,000,000 annually for state grants for substance use disorder treatment under SEC. 5 might lead to concerns about oversight and potential wasteful spending if not managed properly. The lack of detailed criteria or accountability measures could result in inefficient fund distribution and usage.
The prioritization of recovery housing program funding (SEC. 4) which places 70% weight on drug overdose death rates might skew the distribution disproportionately towards states with higher incidence, potentially neglecting the funding for states seeking preventive strategies.
The text across various sections uses the phrase 'out of any monies in the Treasury not otherwise appropriated' (e.g., SEC. 2, SEC. 3, SEC. 4), which may raise issues of budget prioritization and concerns about oversight, as it implies funds are being taken from unspecified Treasury reserves.
SEC. 13 authorizes significant funds ($15,000,000 annually) for law enforcement mental health programs without specific metrics or criteria for success, raising questions about effective use of funds and accountability.
The flexibility in SEC. 5 allowing states to use funds for substance use disorder treatment regardless of primary diagnosis might lead to funds being diverted from opioid-specific programs, impacting the effectiveness of targeted interventions for opioid use disorders.
The extension of Medicaid delivery system reform and incentive payment waivers under SEC. 11 could lead to significant expenditures without clear justifications or evaluation criteria to measure the effectiveness of prolonged extensions.
SEC. 7 introduces complex amendments across various healthcare-related acts, potentially leading to implementation difficulties due to the coordination required among diverse stakeholders and potential financial implications for insurance providers.
The provisions in SEC. 10 regarding Medicaid demonstrations for recovery housing entail elevated capitated budgets, possibly leading to increased expenditures without assurances of cost-effective outcomes if monitoring is insufficient.
The large appropriations for mental and behavioral health education under SEC. 3(e), totaling $75,000,000 annually, lack specificity in oversight, potentially leading to inefficient fund usage.
Appropriations for the support of law enforcement mental health and wellness under SEC. 13 lack oversight measures, raising ethical and financial concerns about effective fund use and program accountability.
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of the Act states that it can be officially called the "Turn the Tide Act."
2. Controlled substance provisions of the SUPPORT for Patients and Communities Act Read Opens in new tab
Summary AI
The section of the bill amends the SUPPORT for Patients and Communities Act by allocating $4 million each year from 2024 to 2027 for grants to improve access to substance use disorder treatment and provides $10 million each year from 2024 to 2027 to increase drug disposal efforts, both from available Treasury funds.
Money References
- (a) Grants To enhance access to substance use disorder treatment.—Section 3203(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(b) Appropriations.—For grants under subsection (a), there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $4,000,000 for each of fiscal years 2024 through 2027.”
- “To carry out this chapter, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $10,000,000 for each of fiscal years 2024 through 2027.”.
3260. Appropriations Read Opens in new tab
Summary AI
The section authorizes the allocation of $10 million each year from 2024 to 2027 from the U.S. Treasury for initiatives described in the chapter, using funds that aren't designated for any other purpose.
Money References
- To carry out this chapter, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $10,000,000 for each of fiscal years 2024 through 2027.
3. Public Health provisions of the SUPPORT for Patients and Communities Act Read Opens in new tab
Summary AI
The SUPPORT for Patients and Communities Act includes multiple amendments to public health provisions. Each amendment specifies funds to be allocated from the Treasury for various programs related to substance use disorder prevention, mental health education, opioid recovery centers, training grants, and other related initiatives, with specific amounts designated for fiscal years 2024 through 2027.
Money References
- (a) First responder training.—Section 546(h) of the Public Health Service Act (42 U.S.C. 290ee–1(h)) is amended to read as follows: “(h) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $56,000,000 for each of fiscal years 2024 through 2027.”
- (b) Public health laboratories pilot program.—Section 7011(d) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(d) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $15,000,000 for each of fiscal years 2024 through 2027.”
- (c) Model training programs for substance use disorder patient records.—Section 7053(e) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(e) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated— “(1) $4,000,000 for fiscal year 2024; “(2) $2,000,000 for fiscal year 2025; and “(3) $1,000,000 for each of fiscal years 2026 and 2027.”. (d) Residential treatment programs for pregnant and postpartum women.—Section 508(s) of the Public Health Service Act (42 U.S.C. 290bb–1(s)) is amended by striking the first sentence and inserting the following: “To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $40,000,000 for each of fiscal years 2024 through 2027.”. (e) Mental and behavioral health education and training grants.—Section 756(f) of the Public Health Service Act (42 U.S.C. 294e–1(f)) is amended to read as follows: “(f) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $75,000,000 for each of fiscal years 2024 through 2027.”
- (f) Coordination and continuation of care for drug overdose patients.—Section 7081(f) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(f) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $10,000,000 for each of fiscal years 2024 through 2027.”
- (g) Emergency department alternatives to opioids demonstration program.—Section 7091(g) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(g) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $10,000,000 for each of fiscal years 2024 through 2027.”
- (h) Regional centers of excellence in substance use disorder education.—Section 551(f) of the Public Health Service Act (42 U.S.C. 290ee–6(f)) is amended to read as follows: “(f) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $4,000,000 for each of fiscal years 2024 through 2027.”
- (i) Youth prevention and recovery.—Section 7102(c)(9) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(9) APPROPRIATIONS.—To carry out this subsection, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $18,000,000 for each of fiscal years 2024 through 2027.”.
- (j) Comprehensive opioid recovery centers.—Section 552(j) of the Public Health Service Act (42 U.S.C. 290ee–7(j)) is amended to read as follows: “(j) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $10,000,000 for each of fiscal years 2024 through 2027.”.
- (k) CDC surveillance and data collection.—Section 7131(e) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(e) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $2,000,000 for each of fiscal years 2024 through 2027.”
- (l) National child traumatic stress initiative.—Section 582(j) of the Public Health Service Act (42 U.S.C. 290hh–1(j)) is amended to read as follows: “(j) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $112,000,000 for each of fiscal years 2024 through 2027.”.
- (m) Trauma support services and mental health care.—Section 7134(l) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(l) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $50,000,000 for each of fiscal years 2024 through 2027.”
- (n) Surveillance and education regarding infections associated with illicit drug use and other risk factors.—Section 317N(d) of the Public Health Service Act (42 U.S.C. 247b–15(d)) is amended to read as follows: “(d) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $40,000,000 for each of fiscal years 2024 through 2027.”. (o) Building communities of recovery.—Section 547(f) of the Public Health Service Act (42 U.S.C. 290ee–2(f)) is amended to read as follows: “(f) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $16,000,000 for each of fiscal years 2024 through 2027.”
- (p) Peer support technical assistance center.—Section 547A(e) of the Public Health Service Act (42 U.S.C. 290ee–2a(e)) is amended to read as follows: “(e) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $2,000,000 for each of fiscal years 2024 through 2027.”
- (q) Preventing overdoses of controlled substances.—Section 392A(d) of the Public Health Service Act (42 U.S.C. 280b–1(d)) is amended to read as follows: “(d) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $506,000,000 for each of fiscal years 2024 through 2027.”.
- (r) Career Act.—Section 7183(k) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(k) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $12,000,000 for each of fiscal years 2024 through 2027.”.
4. Housing and Department of Justice provisions of the SUPPORT for Patients and Communities Act Read Opens in new tab
Summary AI
The SUPPORT for Patients and Communities Act is updated to extend funding for various programs focusing on housing, opioid abuse, and drug control policies from 2024 through 2027. This includes changes to funding allocations and priorities, such as emphasizing areas with high overdose rates, and appropriating specific funding amounts for multiple drug-related programs and initiatives.
Money References
- (a) Reauthorization and improvement of recovery housing program.—Section 8071 of the SUPPORT for Patients and Communities Act (42 U.S.C. 5301 note; Public Law 115–271) is amended— (1) in subsection (a), by striking “such sums as may be necessary for each of fiscal years 2019 through 2023” and inserting “$60,000,000 for each of fiscal years 2024 through 2029”; (2) in subsection (b)— (A) in paragraph (1), by striking “date of enactment of this Act” and inserting “date of enactment of the Turn the Tide Act”; and (B) by striking paragraph (2) and inserting the following: “(2) PRIORITY.
- “(iii) The rate described in subparagraph (A)(iii) shall be weighted at 70 percent.”; and (3) in subsection (c)(1), by striking “at least 30 percent of such funds within one year” and inserting “at least 50 percent of such funds within 2 years”. (b) Building capacity for family-Focused residential treatment.—Section 8083(c) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (Public Law 115–271) is amended to read as follows: “(c) Appropriations.—To carry out this section, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $20,000,000 for fiscal years 2024, which shall remain available through fiscal year 2027.”
- (c) Comprehensive Opioid Abuse Grant Program.—Section 1001(a)(27) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10261(a)(27)) is amended to read as follows: “(27) To carry out part LL, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $500,000,000 for each of fiscal years 2024 through 2027.”
- (d) Office of National Drug Control Policy.—Section 714 of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1711) is amended to read as follows: “SEC. 714. Authorization of appropriations; appropriations. “To carry out this title, except activities otherwise specified, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $50,000,000 for each of fiscal years 2024 through 2027, to remain available until expended.”.
- (e) Drug-Free Communities Program.—Section 1024 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1524) is amended— (1) in the heading, by inserting “; appropriations” after “Authorization of appropriations”; and (2) by striking subsection (a) and inserting the following: “(a) In general.—To carry out this chapter, there is authorized to be appropriated to the Office of National Drug Control Policy, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $175,000,000 for each of fiscal years 2024 through 2027.
- (f) High-Intensity Drug Trafficking Area Program.—Section 707(p) of the Office of National Drug Control Policy Reauthorization Act of 1988 (21 U.S.C. 1706(p)) is amended— (1) by redesignating paragraphs (1) through (6) as subparagraphs (A) through (F), respectively, and adjusting the margins accordingly; (2) by striking “There is authorized” and inserting the following: “(1) IN GENERAL.—There is authorized”; (3) in paragraph (1), as so designated— (A) in subparagraph (E), as so redesignated, by striking “each of”; and (B) in subparagraph (F), as so redesignated, by striking “2018 through 2023” and inserting “2024 through 2027”; and (4) by adding at the end the following: “(2) APPROPRIATIONS.—To carry out this section, there is authorized to be appropriated to the Office of National Drug Control Policy, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $350,000,000 for each of fiscal years 2024 through 2027.”. (g) Drug Court Program.—Section 1001(a)(25)(A) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10261(a)(25)(A)) is amended to read as follows: “(25)(A) Except as provided in subparagraph (C), to carry out part EE, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $125,000,000 for each of fiscal years 2024 through 2027.”. (h) Drug Court Training and Technical Assistance.—Section 705(e)(2) of the Office of National Drug Control Policy Reauthorization Act of 1988 (21 U.S.C. 1704(e)(2)) is amended to read as follows: “(2) AUTHORIZATION OF APPROPRIATIONS; APPROPRIATIONS.—To carry out this subsection, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $5,000,000 for each of fiscal years 2024 through 2027.”. (i) Administration of the Office of National Drug Control Policy.—Section 704(i)(2) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1703(i)(2)) is amended to read as follows: “(2) AUTHORIZATION OF APPROPRIATIONS; APPROPRIATIONS.—To carry out this subsection, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $1,750,000 for each of fiscal years 2024 through 2027.”. (j) Emerging Threats Committee, Plan, and Media Campaign.—Section 709(g) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1708(g)) is amended to read as follows: “(g) Authorization of appropriations; appropriations.—To carry out this section, there is authorized to be appropriated to the Office, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $35,000,000 for each of fiscal years 2024 through 2027.”. ---
714. Authorization of appropriations; appropriations Read Opens in new tab
Summary AI
The section authorizes $50,000,000 to be both set aside and spent from the U.S. Treasury for each fiscal year from 2024 to 2027, with no time limit on when the money must be used.
Money References
- To carry out this title, except activities otherwise specified, there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $50,000,000 for each of fiscal years 2024 through 2027, to remain available until expended. ---
5. Bolstering commitments to State grants for substance use disorder treatment and prevention Read Opens in new tab
Summary AI
The bill section allocates funding to help states and Indian tribes handle substance use disorders, emphasizing opioid-related issues, from 2024 to 2033. It sets specific funding distribution rules, such as reserving funds for Indian tribes and states with high opioid death rates, while ensuring a minimum amount is given to each state and the District of Columbia.
Money References
- — (1) IN GENERAL.—To carry out activities under section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee–3 note) relating to opioids by the State agency responsible for administering the substance abuse prevention and treatment block grant under subpart II of part B of title XIX of the Public Health Service Act (42 U.S.C. 300x–21 et seq.), there is authorized to be appropriated, and there is appropriated, $5,500,000,000 for each of fiscal years 2024 through 2028.
- (3) SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANTS.—Section 1935(a) of the Public Health Service Act (42 U.S.C. 300x–35(a)) is amended to read as follows: “(a) Appropriations.—To carry out this subpart, subpart III, and section 505(d), there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $3,000,000,000 for each of fiscal years 2024 through 2028, and $2,500,000,000 for each of fiscal years 2029 through 2033.”
- (b) Requirements.—For the purposes of carrying out activities with amounts appropriated under this section (and the amendment made by this section), the Secretary of Health and Human Services shall ensure that the following requirements are complied with: (1) Of the amount appropriated for each fiscal year under subsection (a) (and the amendment made by such subsection), $50,000,000 shall be made available to Indian Tribes or tribal organizations. (2) Of such remaining amounts for each such fiscal year, 15 percent shall be made available to the States with the highest mortality rate related to opioid use disorders.
- (7) Each State, including the District of Columbia, shall receive not less than $4,000,000 under grants under this section.
- (8) In addition to amounts appropriated under this section (and the amendment made by this section), the following amounts shall be available under section 241 of the Public Health Service Act (42 U.S.C. 238j): (A) $79,200,000 to carry out subpart II of part B of title XIX of the Public Health Service Act to fund section 1935(b) (42 U.S.C. 300x–35) (relating to technical assistance, national data, data collection and evaluation activities) and the total available under this Act for activities under such section 1935(b) shall not exceed 5 percent of the amounts appropriated for such subpart II of part B of title XIX.
- (B) $2,000,000 to evaluate substance abuse treatment programs.
6. Eliminating insurance barriers to medication-assisted treatment Read Opens in new tab
Summary AI
The text describes changes to the Social Security Act that eliminate insurance barriers for medication-assisted treatment by prohibiting states from imposing utilization control policies, like prior authorization, for such treatments. These changes will take effect on October 1, 2024.
7. Limitations on cost-sharing for opioid overdose reversal medications Read Opens in new tab
Summary AI
The section mandates that health plans, including public and private insurance, must cover at least one type of opioid overdose reversal drug without charging patients. Effective from 2025, plans can't impose usage barriers like requiring prior authorization, and this rule also extends to Medicare Part D, ensuring low-income individuals do not face cost-sharing for these life-saving medications.
2799A–11. Limitations on cost-sharing for opioid overdose reversal agents Read Opens in new tab
Summary AI
A group health plan or health insurance must cover at least one type of medication that can reverse an opioid overdose without requiring any additional payment from the patient. They also cannot set any restrictions like prior approval on accessing these medications, although they can manage how the benefits are provided.
726. Limitations on cost-sharing for opioid overdose reversal agents Read Opens in new tab
Summary AI
A group health plan or health insurance must cover at least one form of medication that reverses opioid overdoses without charging any extra fees to plan members. Additionally, they cannot require special approval processes for these medications, but they can manage how the benefits are provided.
9826. Limitations on cost-sharing for opioid overdose reversal agents Read Opens in new tab
Summary AI
A group health plan must cover at least one type of opioid overdose reversal agent and cannot charge patients for it. Additionally, such plans cannot use policies like pre-approval requirements to control access to these agents but can manage how benefits are provided.
8. Targeting health workforce loan repayment assistance to hardest-hit States Read Opens in new tab
Summary AI
The bill section increases funding for loan repayment and training programs for the substance use disorder treatment workforce. It raises the budget for loan repayment to $50 million annually from 2024 to 2028 and allocates additional funding for states with the highest drug overdose death rates, providing $20 million annually for these states from 2024 to 2027.
Money References
- (a) Loan repayment program for substance use disorder treatment workforce.—Section 781 of the Public Health Service Act (42 U.S.C. 295h) is amended— (1) in subsection (b), by adding at the end the following: “(3) TAX LIABILITY.—The amount of a payment made under this section on behalf of an individual shall not be considered income for any purpose under the Internal Revenue Code of 1986.”; and (2) in subsection (j), by striking “$25,000,000 for each of fiscal years 2019 through 2023” and inserting “$50,000,000 for each of fiscal years 2024 through 2028”. (b) Training demonstration program.—Section 760(g) of the Public Health Service Act (42 U.S.C. 294k(g)) is amended to read as follows: “(g) Appropriations.— “(1) IN GENERAL.—To carry out this section (other than paragraph (2)), there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $10,000,000 for each of fiscal years 2024 through 2027. “(2) STATES WITH HIGHEST DRUG OVERDOSE DEATH RATES.
- — “(A) IN GENERAL.—To carry out the program under this section with respect to grantees located in States described in subparagraph (B), there is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $20,000,000 for each of fiscal years 2024 through 2027. “(B) STATES DESCRIBED.—A State described in this subparagraph is a State that is among the top 10 States in terms of highest per capita drug poisoning deaths in each of calendar years 2019, 2020, and 2021, based on the most recent data available from the Centers for Disease Control and Prevention.
9. Medicaid payments for behavioral health and mental health providers Read Opens in new tab
Summary AI
This section of the bill aims to ensure that Medicaid pays healthcare providers, including doctors and certain mental health professionals, at fair rates for mental and behavioral health services related to substance use disorders. It also provides states extra federal funding to cover the costs of these services from October 2024 to October 2028.
10. CMI demonstration to test the provision of recovery housing for individuals with opioid use disorder under Medicaid Read Opens in new tab
Summary AI
The CMI is testing a program to provide recovery housing for Medicaid recipients with opioid use disorder by offering extra funding and flexibility to states. If the program shows reduced emergency visits or improves care without raising costs, it could become a permanent Medicaid feature.
11. Extension of Medicaid delivery system reform and incentive payment waivers Read Opens in new tab
Summary AI
The text explains that the Secretary of Health and Human Services must extend certain Medicaid waivers for states with high drug poisoning deaths until December 31, 2026. These waivers, initially set to end by December 31, 2024, allow states to continue using the same funding levels and to train workers providing home and community-based services.
Money References
- (a) Extension of waivers.—In the case of a Medicaid section 1115 waiver described in subsection (b), not later than 60 days after the date of enactment of this Act, the Secretary of Health and Human Services shall— (1) extend the termination date for the waiver to December 31, 2026 (or such earlier date as the State conducting the waiver may elect); (2) apply the same annual dollar allotment for the period for which the waiver is extended under paragraph (1) as the annual dollar allotment that applied to the waiver period in effect on the date of enactment of this Act; and (3) allow any State with such a waiver to use funds provided during the period for which the waiver is extended under paragraph (1) to support the training of direct service workers that provide home and community-based services.
12. Expanding Drug-Free Communities support grants Read Opens in new tab
Summary AI
The amendment to the Anti-Drug Abuse Act of 1988 expands the types of grants available for drug-free communities by allowing for additional and renewal grants based on non-federal funds raised by the grant recipient. It gives priority to communities in economically disadvantaged areas and states with high opioid-related mortality rates, and it limits subsequent renewal grants so that recipients cannot receive further grants under this section after a certain point.
13. Support for law enforcement mental health and wellness Read Opens in new tab
Summary AI
The section authorizes $15 million per year from 2024 to 2027 to support peer mentoring and mental health wellness programs for law enforcement officers. These funds are intended for use by State, Tribal, and local law enforcement agencies, helping them to establish mental health pilot programs.
Money References
- There is authorized to be appropriated, and there is appropriated, out of any monies in the Treasury not otherwise appropriated, $15,000,000 for each of fiscal years 2024 through 2027 for grants under section 1701(b)(23) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10381(b)(23)) to establish peer mentoring mental health and wellness pilot programs within State, Tribal, and local law enforcement agencies.
14. Adverse childhood experiences response team grant program Read Opens in new tab
Summary AI
The bill section establishes a grant program funded by the federal government to help states, local governments, Indian Tribes, and community organizations support children who experience trauma. It provides $10 million per year from 2024 to 2027 to create response teams, develop partnerships, integrate services, and offer training in trauma-informed care.
Money References
- (b) Authorization of appropriations.—Section 1001(a) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10261(a)) is amended by adding at the end the following: “(29) There are authorized to be appropriated to carry out part PP $10,000,000 for each of fiscal years 2024 through 2027.”.
3061. Grants for adverse childhood experiences response teams Read Opens in new tab
Summary AI
The bill section authorizes the Attorney General, with the Secretary of Health and Human Services, to provide grants to various entities like states and local governments to create response teams for helping children who have experienced trauma. The funds can be used for activities such as developing support programs, training service providers, and coordinating with health and law enforcement services to ensure children get the necessary help and care.